AccessibilityHelp
Drug Free Solution logo

Drug Free Solution(OTC) DSOL

Market Cap$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-100%
5 Year-98%
1 Year-64%
1 Month+0%
$0.00
+0.00%
+0.00Today
Drug Free Solution last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-14
Drug Free Solution stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-17
1 month+0%USD 0.002026-07-17
3 month+100%USD 0.002026-05-14
Year to date-63.64%USD 0.002025-11-10
1 year-63.64%USD 0.002025-09-26
3 year+100%USD 0.002023-07-27
5 year-97.65%USD 0.022021-09-27
Since inception-99.91%USD 0.452012-11-09

Drug Free Solution Financials at a Glance

Market Cap

$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.10

Net Income (TTM)

-$10.59K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-16.05 (Low)

Price

$0.00

Volume

10

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

N/A

DSOL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drug Free Solution

Drug Free Solution, Inc. is a lifestyle enterprise based in El Segundo, California, dedicated to enhancing emotional well-being. The company specializes in innovative techniques aimed at addiction prevention, personal growth, and overall lifestyle enhancement.

Products and Services
  • Proprietary "Living Breath Process" for emotional health
  • "Living Breath Series" of educational programs and resources
  • Community wellness initiatives through the "Living Breath Project"
Growth Outlook
  • Focus on addiction recovery aligns with increasing national health concerns
  • Potential for expansion into community wellness centers and correctional facilities
  • Growing demand for emotional well-being solutions in the healthcare sector
Financial Highlights
  • Recent quarterly net income of -$8,406, reflecting ongoing operational challenges
  • Trailing twelve months (TTM) revenue remains at $0, indicating a need for strategic growth
  • Market capitalization of approximately $113,361, suggesting potential for investor interest
Drug Free Solution, Inc. operates within the healthcare information services industry, focusing on innovative methods to address emotional and psychological challenges. The company's flagship offering, the "Living Breath Process," integrates self-reflection and guided breathing techniques, catering to individuals seeking personal growth and addiction recovery. Additionally, the "Living Breath Series" provides educational resources that support these initiatives. The growth outlook for Drug Free Solution, Inc. is promising, particularly as the national conversation around mental health and addiction continues to evolve. The company's commitment to establishing community wellness centers and support networks positions it well to meet the increasing demand for effective emotional health solutions. Financially, the company faces challenges, as evidenced by its recent quarterly net income and TTM revenue figures. However, the low market capitalization may present an opportunity for investors looking for potential growth in a sector that is gaining traction. Overall, Drug Free Solution, Inc. represents a unique approach to emotional well-being, with a focus on community impact and personal development.
AI Generated • Sep 27, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Jessica Bass

Website

www.drugfreesolution.com

Headquarters

Irvine, CA 92612, US

DSOL Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

2.58%

Return on Capital

N/A

Return on Assets

-12.74%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

283.40M

Volume

10

Avg. Volume

0.154

Financials (TTM)

Gross Profit

-$0.83

Operating Income

-$10.59K

EBITDA

-$250.04K

Operating Cash Flow

-$735.45

Capital Expenditure

-$27.66

Free Cash Flow

-$763.11

Cash & ST Invst.

$7.12

Total Debt

$0.00

Drug Free Solution Performance Analysis

Drug Free Solution annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-05-31USD 0N/A
20232023-05-31USD 0N/A
20242024-05-31USD 0N/A
20252025-05-31USD 0N/A
Drug Free Solution sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22013-11-30N/A
Q32014-02-28-100.0%
Q32021-02-28N/A
Q12024-08-31N/A
Drug Free Solution annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-05-31USD 0.00N/A
20232023-05-31USD -0.00N/A
20242024-05-31USD 0.00N/A
20252025-05-31USD 0.00N/A
Drug Free Solution sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22013-11-30-100.0%
Q32014-02-288.3%
Q32021-02-28N/A
Q12024-08-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$56.70K

N/A

Employees

2

N/A

Net Income

-$8.41K

-16548.8%

EBITDA

-$8.41K

+83.3%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Total Cash

$7.12

-72.8%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-12.74%

N/A

Return on Invested Capital

2.38%

N/A

Free Cash Flow

-$102.51

-185.5%

Operating Cash Flow

-$102.51

-179.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AHGIFAlternate Health Corp.
$0.00+0.00%
RDGLVivos Inc.
$0.04-3.86%
ITHUFiAnthus Capital Holdings, Inc.
$0.00-4.76%
MDDVFMedical Developments International Limited
$0.27+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About DSOL

What is the current price of Drug Free Solution?

Drug Free Solution is trading at $0.00 per share.

What is the 52-week range for Drug Free Solution?

Over the past 52 weeks, Drug Free Solution has traded between $0.00 and $0.04.

How much debt does Drug Free Solution have?

As of the most recent reporting period, Drug Free Solution reported total debt of $0.00.

How much cash does Drug Free Solution have on hand?

Drug Free Solution reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Drug Free Solution’s dividend yield?

Drug Free Solution does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services